CCNE2 and breast carcinoma: Moreover, a multivariate analysis of a cohort of 1131 breast cancer patients (a subset of our meta-dataset) revealed that a low expression level of CCNE2, as well as negative lymph node status, is a significant (P = 0.01) independent factor of good prognosis (Figure 2c).